Detalles de la búsqueda
1.
Factors associated with immune responses to SARS-CoV-2 vaccination in autoimmune disease individuals.
JCI Insight;
2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38833310
2.
Neutrophils isolated from systemic lupus erythematosus patients exhibit a distinct functional phenotype.
Front Immunol;
15: 1339250, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38524128
3.
Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial.
Arthritis Rheumatol;
76(1): 59-67, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37466424
4.
Ancestry-based differences in the immune phenotype are associated with lupus activity.
JCI Insight;
8(16)2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37606045
5.
Protocol for virtual physical examination in an observational, longitudinal study evaluating virtual outcome measures in SLE.
Lupus Sci Med;
10(2)2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37429672
6.
A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus.
Arthritis Rheumatol;
75(5): 723-735, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36245261
7.
Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus Nephritis.
Arthritis Care Res (Hoboken);
75(7): 1399-1408, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36039949
8.
Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies.
Front Immunol;
12: 635072, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34122404
9.
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Lancet;
397(10289): 2070-2080, 2021 05 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33971155
10.
A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified Lupus.
ACR Open Rheumatol;
3(2): 116-123, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33538130
11.
Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus.
J Transl Autoimmun;
4: 100117, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35005588
12.
Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints.
Kidney Int Rep;
5(8): 1302-1305, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32775830
13.
Cell-bound complement activation products associate with lupus severity in SLE.
Lupus Sci Med;
7(1)2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32371480
14.
Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype.
J Allergy Clin Immunol;
146(6): 1419-1433, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32446964
15.
Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers.
Lupus Sci Med;
7(1): e000360, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32201595
16.
Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study.
EClinicalMedicine;
20: 100291, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32154507
17.
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.
Arthritis Rheumatol;
72(1): 78-88, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31469249
18.
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures.
Lupus Sci Med;
6(1): e000365, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31921432
19.
Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.
Arthritis Rheumatol;
71(3): 411-419, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30225865
20.
Mock Recruitment for the Study of Antimalarials in an Incomplete Lupus Erythematosus Trial.
Arthritis Care Res (Hoboken);
71(11): 1425-1429, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30369087